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AbstrACt
Objective To assess the feasibility of using a blood 
pressure (BP) self-measurement kiosk—a solid-cuff 
sphygmomanometer combined with technology to 
integrate the BP readings into patient electronic medical 
records— to improve hypertension detection.
Design A concurrent mixed-methods feasibility study 
incorporating observational and qualitative interview 
components.
setting Two English general practitioner (GP) surgeries.
Participants Adult patients registered at participating 
surgeries. Staff working at these sites.
Interventions BP self-measurement kiosks were placed 
in the waiting rooms for a 12-month period between 2015 
and 2016 and compared with a 12-month control period 
prior to installation.
Outcome measures (1) The number of patients using 
the kiosk and agreeing to transfer of their data into their 
electronic medical records; (2) the cost of using a kiosk 
compared with GP/practice nurse BP screening; (3) 
qualitative themes regarding use of the equipment.
results Out of 15 624 eligible patients, only 186 (1.2%, 
95% CI 1.0% to 1.4%) successfully used the kiosk to 
directly transfer a BP reading into their medical record. 
For a considerable portion of the intervention period, no 
readings were transferred, possibly indicating technical 
problems with the transfer link. A comparison of costs 
suggests that at least 52.6% of eligible patients would 
need to self-screen in order to bring costs below that 
of screening by GPs and practice nurses. Qualitative 
interviews confirmed that both patients and staff 
experienced technical difficulties, and used alternative 
methods to enter BP results into the medical record.
Conclusions While interviewees were generally positive 
about checking BP in the waiting room, the electronic 
transfer system as tested was neither robust, effective 
nor likely to be a cost-effective approach, thus may not be 
appropriate for a primary care environment. Since most of 
the cost of a kiosk system lies in the transfer mechanism, 
a solid-cuff sphygmomanometer and manual entry of 
results may be a suitable alternative.
IntrODuCtIOn
Hypertension is a major risk factor for 
adverse cardiovascular events such as stroke 
and myocardial infarction.1 Interventions to 
reduce blood pressure (BP), including both 
lifestyle modifications such as changes in diet 
and physical activity levels and antihyperten-
sive medication, can reduce cardiovascular 
mortality and morbidity in the hyperten-
sive population,2–6 and are cost-effective.7 8 
However, as raised BP is typically asymptom-
atic, screening is necessary to detect those 
requiring a formal diagnostic process for 
hypertension and subsequently provide them 
with effective management.9 10 
In the UK, BP screening has typically been 
carried out by clinicians in an ad hoc manner—
monitoring patients who may be presenting 
for other reasons.11 Regular measurement of 
BP in adults has been included in the National 
Health Service (NHS) Quality Outcomes 
Framework since 2004.12 The introduction of 
the NHS Health Check in 2008 further incen-
tivised screening of all adults aged 40–74 
years, providing the opportunity to capture 
those who do not require or request routine 
medical care, and would be missed by oppor-
tunistic screening.13
The advent of solid-cuff sphygmomanom-
eters14 has allowed BP screening to move 
from the consultation into the waiting 
room.15 Patients can use these BP moni-
tors without any assistance from staff, and 
monitors are often equipped with printers, 
allowing the result to be reliably recorded. 
strengths and limitations of this study
 ► Blood pressure (BP) self-screening kiosks offer the 
potential by which to address the paucity of studies 
investigating the impact of BP self-screening on hy-
pertension diagnosis.
 ► Adopting a mixed-methods approach enables a 
more complete picture of feasibility to be painted.
 ► The study design relies on quantitative data being 
present and extractable from electronic medical 
records.
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However, to date, there is still a need for manual interven-
tion from staff to enter the BP reading into the patient’s 
electronic medical record and interpret it.
A number of manufacturers now offer kiosks that 
combine a solid-cuff sphygmomanometer with a computer 
interface, allowing the patient to identify themselves with 
links to the local clinical system, so that any BP readings 
are automatically added to the patient’s medical record. 
These kiosks typically include the option to set thresholds 
to notify clinicians of BP readings that are outside accept-
able ranges, so that patients can be recalled for further 
tests if necessary. They may also provide the opportunity 
to carry out other forms of screening such as weight or 
screening questionnaires (eg, https://www. thsl. co. uk/ 
products/ surgerypod- 2).
In this study, we assessed the feasibility of using such 
a kiosk to improve detection of hypertension in the 
community using a mixed-methods approach.
MethODs
Quantitative data
We selected a BP self-measurement kiosk device 
(SurgeryPod Plus, Medvivo latterly Microtech, UK) that 
was able to interface with various UK NHS general practice 
electronic health record systems, and which took seated 
BP using an clinically validated sphygmomanometer. BP 
self-measurement kiosks were placed in the waiting room 
areas of two general practitioner (GP) surgeries in the 
UK. The practices were selected due to their differing 
sizes, patient population characteristics and IT systems. 
The intention was to also include a pharmacy site, but no 
pharmacy partner who was willing and able to participate 
could be identified.
The kiosks combined a clinically validated solid-cuff 
automated sphygmomanometer (TM-2655P, A&D Instru-
ments, UK), supporting arm circumferences from 17 to 
45 cm, with a dedicated touch screen computer inter-
face.14 The touch screen allowed the patient to identify 
themselves within the practice list, and then guided them 
through the BP measurement. Patients were asked to 
take three BP measures within a single session, and were 
then offered the opportunity to have the readings trans-
ferred to their electronic medical record. A measurement 
session lasted about 4 min. If the BP reading(s) were 
above the predefined trigger level of 135/85 mm Hg, and 
the patient had agreed to the transfer of their results, 
the kiosk software would trigger an email to a nomi-
nated practice account. The trigger level was chosen to 
match the clinical threshold for home and ambulatory BP 
measurement in the UK National Institute for Health and 
Care Excellence guidelines.10
This commercially available system was chosen over 
other products because it measured seated BP via a vali-
dated device, was UK based and integrated the results 
into the electronic medical record system enabling quan-
titative evaluation.
A kiosk was installed in the waiting room area of each of 
the two participating GP surgeries for a 12-month period 
with a 12-month control period prior to installation of the 
kiosk also identified. At the end of the study period, the 
following anonymised data were extracted from the elec-
tronic medical record:
 ► Demographics (age, gender, ethnicity) of population 
using the kiosk.
 ► Hypertension diagnosis dates for patients registered 
during both the study and control periods.
 ► All BP recorded during the study and control periods, 
including those recorded using the kiosk.
 ► Use of home and ambulatory BP monitoring during 
the study and control periods.
 ► All clinician consultations during the study and 
control periods.
Data were also collected on medications, cardiovascular 
disease risk scoring, cholesterol blood test results and 
other comorbidities for use in planned health economic 
modelling (see below for economic analyses).
The kiosk was installed in the waiting room of practice 
A from 25 June 2015 to 24 June 2016. The control period 
identified for this site was 9 May 2013 to 8 May 2014. This 
was a year earlier than the immediate intervention period 
due to a typographical error in the search used to extract 
the anonymised data. The intervention period for prac-
tice B was 2 September 2015 to 1 September 2016 and 
the control period was 2 September 2014 to 1 September 
2015.
The manufacturer was able to remotely monitor the 
number of screening sessions based on data transferred 
from the kiosk but not the screening data itself. These 
data were shared with the study team following the 
completion of the study.
To assess the feasibility of the kiosks, the primary 
outcome chosen was the number of patients using them 
and agreeing to transfer of their data into their electronic 
medical records. Investigation of the demographics of 
kiosk users, as well as whether they had a prior hyper-
tension diagnosis, and whether they had any clinician 
measurement of BP during the study period was also 
planned.
It was hypothesised that use of the kiosks by patients 
without a hypertension diagnosis might lead to increased 
detection of undiagnosed hypertension, so rates of hyper-
tension diagnosis in the study and control periods, and 
in those using and not using the kiosk were assessed. 
Similarly, the number of those who screened high on the 
kiosk and subsequently received diagnostic assessment 
for hypertension (defined as home or ambulatory BP 
monitoring) was evaluated.
The potential effect of the kiosks on the clinical work-
load was considered by ascertaining how many people 
screened high on their kiosk reading, and subsequently 
attended for a consultation (without any way of knowing 
if the subsequent consultation was related to the high 
reading). Comparison was made of the rates of clini-
cian measurement of BP during the study and control 
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periods, to see if the presence of the kiosk altered clini-
cian screening workload. This was tested using a X2 test 
with continuity correction.
All numerical analyses were carried out using R V.3.4.2.16
economic analyses
In the light of the results of the study, a simple economic 
analysis was undertaken. The analysis compared the 
cost of a practice using a self-screening kiosk for 1 year, 
with BP screening undertaken by a combination of GPs 
and practice nurses (base case) and also with practice 
nurse only screening and healthcare assistant (HCNA) 
only screening. Using data from the control period of 
one of the practices (practice A), it was calculated that 
2681 patients (53.5% of the adult practice population) 
were aged over 45 years with no diagnosed hyperten-
sion, and with screening every 5 years, one-fifth (n=536) 
could potentially be screened in 1 year. The actual cost 
of hiring a kiosk for 1 year was obtained within the study 
(see online supplementary table 1). For healthcare 
professional screening, the cost for a 5 min appointment 
was obtained for screening by a GP, practice nurse and 
HCNA (see online supplementary table 1).17 Five minutes 
was chosen as the minimum time needed to take a satis-
factory BP measurement. The total costs of screening all 
patients were calculated and compared with the cost of a 
kiosk. The proportion screened via a kiosk was also varied, 
assuming that the remaining patients were screened by 
a healthcare professional. Further modelling was not 
undertaken.
Qualitative data
GPs and practice staff were invited to interview and 
informed consent obtained. The interviews were 
conducted face to face by a non-clinical researcher (AT) 
based on a topic guide informed by the evaluation aims. 
Interview recordings were transcribed and checked. 
Initial transcripts were coded by two researchers in NVivo 
and a coding framework discussed. This was applied to 
the subsequent transcripts and refined. Earlier transcripts 
were re-examined for codes that appeared later in the 
dataset.
As part of a linked study investigating patient experi-
ence of BP measurement during hypertension diagnosis, 
a series of interviews were conducted with patients on the 
hypertension register at the pilot practices (for full details 
see Tompson et al, manuscript submitted). This dataset 
was re-examined for codes regarding the self-screening 
and the kiosk. Codes from the two sets of interviews were 
combined summarised using the one sheet of paper 
technique.18
Mixed-methods approach
In order to gain a more complete picture of feasibility, 
both quantitative and qualitative methods were used 
concurrently to use the strengths and offset the limita-
tions of each approach.19 Following separate analyses, the 
multidisciplinary research team triangulated the findings, 
using qualitative codes from the summarised interview 
data to illustrate and explore the quantitative findings, 
and consider the areas in which there was convergence, 
complementarity or contradiction.20 Due to the composi-
tion of the research team and the biomedical paradigm 
in which they work, the quantitative data were used as the 
‘starting point’ for corroboration when considering the 
study findings.
Table 1 Monitoring data from the kiosk supplier showing the number of kiosk sessions for which data were transferred to the 
practice system during each month of the study period
Month
Practice A Practice B
Sessions transferred Comment Sessions transferred Comment
1 10 No activity for 21 days 40
2 7 No activity for 11 days 30
3 0 No activity 51
4 34 35
5 27 16
6 16 22
7 19 6 No activity for 29 days
8 0 No activity 4 No activity for 11 days, some activity 
and then no activity for 11 days
9 0 No activity 0 No activity
10 0 No activity 0 No activity
11 0 No activity 0 No activity
12 0 No activity 0 No activity
Total 113 204
The actual dates are different for each site due to different intervention start dates.
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Patient and public involvement
Two patient representatives sat on the steering committee 
of the research programme to which this study belonged. 
They commented on the research question, study design, 
methods and draft paper.
results
Quantitative results
We approached three pharmacy chains (representing 
over 4000 pharmacies), but no pharmacies were willing 
to take part. Stated reasons by pharmacies for declining 
participation included reluctance to give up retail space 
to house the kiosk, inability to gain consent from senior 
management, potential disruption to their NHS N3 
internet connection and potential loss of revenue from 
pharmacist-led screening activities.
Two GP surgeries agreed to take part. Practice A 
was in a wealthy suburban village with a list size of 
about 5000 patients. Practice B served a population 
three times larger in an ethnically diverse town. The 
proportions of patients aged over 45 years were 64% 
and 43%, respectively.
When downloading the anonymised data from practice 
B, some technical difficulties were encountered associated 
with the SystmOne electronic medical record system. This 
limited the amount and type of data retrievable at any 
given time. As a result, some of the planned variables were 
not extracted at this site. In addition, some extracted data 
from this practice was found to be of questionable accuracy, 
which limited the analyses that could be carried out. For 
example, when extracting the BP readings made during 
the intervention period at practice B, it was not possible to 
extract any data that would allow identification of which 
readings had been automatically transferred by the kiosk. 
We were able to extract these readings separately using a 
specific search, which permitted analysis within the kiosk 
readings. However, as it was not possible to know which BP 
measurements on a date where a kiosk reading was known 
to have occurred were kiosk measurements, and which 
were practice measurements, we limited analysis of prac-
tice measurements of BP at practice B to those taken on 
dates when there was no kiosk reading for that patient.
use of kiosks
Use of the kiosks at both GP sites was very limited. 
Only 60 patients (1.2%) of the eligible practice popu-
lation at practice A, and 126 patients (1.2%) of the 
eligible population at practice B had at least one 
kiosk measurement successfully transferred to their 
electronic medical records. This included patients 
with existing hypertension diagnoses (13 at practice 
A and 15 at practice B) who were presumably using 
the kiosk for monitoring purposes, as well as ‘true’ 
screening by patients without a pre-existing diagnosis 
of hypertension.
No data were available regarding how many people 
used the kiosks but cancelled the session before transfer-
ring their data, or chose not to transfer their data, or gave 
readings to reception for manual entry. However, moni-
toring data were available from the supplier (table 1) 
showing that for a number of months during the study 
period, no results were transferred. This was particu-
larly noticeable towards the end of the study period at 
both sites, possibly indicating that the kiosks were either 
malfunctioning or that there was an issue with transfer of 
data.
Characteristics of kiosk users
Table 2 describes the characteristics of the patients 
who used the BP self-screening kiosks and agreed to 
Table 2 Characteristics of patients who used a blood pressure (BP) self-screening kiosk and agreed to data transfer
Practice A (n=60) Practice B (n=126)
N (%) female 34/60 (56.7) 59 (47.2)
Mean (SD) age, years 52.57 (16.8) 50.1 (14.8)
Average no of kiosk sessions per user* 1.4 1.3
N (%) with prior diagnosis of hypertension 13 (21.6) 15 (11.9)
N (%) screening positive on kiosk who subsequently attended a consultation†‡ 21/26 (80.8) 18/19 (94.7)
N (%) screening positive on kiosk who had a prior diagnosis of hypertension† 7/26 (26.9) 3/19 (15.8)
N (%) screening positive on kiosk who subsequently underwent assessment for 
hypertension using home or ambulatory BP† ‡
0/26 (0.0) 12/19 (63.2)
N (%) with a practice measurement of BP during the intervention period 32 (53.3) 26 (20.6)§
N (%) with a practice measurement of BP during the intervention period before the 
first kiosk measurement
23 (38.3) 0 (0)
N (%) with a practice measurement of BP during the intervention period after the 
first kiosk measurement
25 (41.7) 26 (20.6)
*Multiple readings on a single day are counted as a single session.
†Positive screening defined as a systolic reading of over 135 mm Hg and/or diastolic reading of over 85 mm Hg.
‡Subsequently defined as on any day after the positive screening was taken on. 
§Measurements taken on the same date as kiosk measurements were excluded as indistinguishable from kiosk readings.
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the electronic transfer of the results into their medical 
records (see online supplementary table 2 for details of 
their ethnicity). At both sites, people with and without an 
existing hypertension diagnosis used the kiosk as both a 
screening and monitoring device. The mean number of 
sessions per user suggests that some were using the device 
for repeated measures (ie, monitoring) over time.
Only 45 users across both sites had a high kiosk reading 
(>135 mm Hg and/or >85 mm Hg). These patients were 
likely to subsequently attend a consultation. Unfortu-
nately, we have no knowledge of whether hypertension 
was discussed or whether the kiosk result was accessed by 
the treating clinician, although it would have been avail-
able to them on the patient’s electronic medical record. 
The two sites showed a very different likelihood of subse-
quent diagnostic assessment for hypertension by home 
or ambulatory monitoring following an elevated kiosk 
reading. This may be related to the locally used methods 
of diagnosis: practice A had low use of out-of-office moni-
toring across both the control and intervention periods 
(see online supplementary table 3). At both sites, there 
was a higher proportion of patients with a (non-kiosk) 
practice measurement of BP recorded in the period after 
their first kiosk measurement than in the period before 
their first kiosk measurement. However, this increase 
was only significant at site B. At site A, the proportion 
increased by 3.3% (95% CI 16% decrease to 23% increase, 
p=0.85), whereas at site B, the proportion increased by 
20.6% (95% CI 13% increase to 28% increase, p<0.001).
Practice-level results
The number of patients with successful transfer of kiosk 
data into their medical records represented 1.2% (95% 
CI 1.0% to 1.4%) of the practice population at each site 
(table 3). Between control and intervention periods, the 
proportion of patients receiving BP measurement by 
clinicians changed in both practices, although not in a 
consistent direction. In practice A, there was a statistically 
significant 4.0% reduction in BP measurement activity 
(95% CI 2.1% to 5.8% decrease in activity, p<0.001). 
In practice B, there was a statistically significant 6.4% 
increase in clinician BP measurement activity (95% CI 
5.5% to 7.3% increase in activity, p<0.001).
economic results
The cost of the hire of a kiosk for a year was £4000. Extrap-
olating from data on registered patients and consultations 
with BP measurement from the control period in practice 
A, it was assumed that screening would be undertaken 
by a combination of GPs (72.0%) and practice nurses 
(28.0%). For the kiosk to be cost neutral (ie, equivalent 
to the cost of GPs/nurses doing the same activity) at least 
52.6% of patients would need to self-screen, compared 
with the 1.2% who actually used the kiosk.
At the level of use recorded in this study, a kiosk 
would cost a practice an additional £3909 a year. When 
comparing the cost of 100% self-screening with practice 
nurse only screening or HCNA only screening, the kiosk 
would cost a practice an additional £2123 or £2972 a year, 
respectively. These costs do not include the additional use 
of the kiosk for BP monitoring in those already diagnosed 
with hypertension. That would require an additional 607 
or 1564 patients to use the kiosk (depending on the 
comparator—nurse or HCNA, respectively) for moni-
toring, in order to break even.
Qualitative results
Table 4 describes the interviewee characteristics: Nine 
interviews were conducted with GPs and practice staff (5, 
55.6% were female) while 29 interviewees were patients 
Table 3 Impact of self-screening kiosks on hypertension detection and general practitioner practice workloads
Period
Practice A Practice B
Control Intervention Control Intervention
Eligible population (registered, aged >18 years) 5008 5137 9665 10 487
N (%) of eligible population using kiosk - 60 (1.2) - 126 (1.2)
N (%) of new hypertensive patients detected 50 (1.0) 41 (0.8) 33 (0.3) 14 (0.1)
N (%) of new hypertensive patients who used the kiosk - 6 (10.0) - 0 (0.0)
N (%) of patients receiving blood pressure measurement 
by clinicians
1810 (36.1) 1652 (32.2) 850 (8.8) 1593 (15.2)
All kiosk usage refers to use where patients agreed to data transfer
Table 4 Characteristics of Interviewees
Practice A Practice B
General practitioner (GPs) and 
practice Staff
(n=9)
3 GPs (2 partners, 1 salaried),
1 practice nurse, 1 member of reception/
management team
2 GPs (both partners),
1 healthcare assistant, 1 member of 
reception/management team
Patients with hypertension
(n=29)
13 (6, 46.2% had used the kiosk) 16 (5, 31.3% had used the kiosk)
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(15, 51.7% were female). Three themes from the data 
are described: The ‘utilisation’ theme presented below 
explores the quantitative usage data and its capture. 
The ‘location and ownership’ and ‘impact’ themes offer 
insights into the systems’ day-to-day (non-) functioning, 
providing some insight into the quantitative findings.
utilisation
The qualitative data provided a broader, complementary 
view19 to the quantitative evaluation which relied on only 
data automatically placed in the medical records by the 
self-screening system. The latter could not quantify the 
number of patients that measured their BP in the waiting 
room that were (1) unable or (2) unwilling to transfer 
their data into their medical records. For example, 
although the quantitative search did not identify any 
patients who were detected as hypertensive via the kiosk 
at practice B, the interview sample did include someone 
who met this criteria: ‘I was coming out from seeing the 
physio so, and I just saw it there and I thought 'well I’ll, I 
might as well do it’ (patient ID22, practice B). His kiosk 
reading was elevated and he was subsequently diagnosed 
as hypertensive.
Converging with the data provided by the system 
provider (table 1), the interviews demonstrated that the 
intended functioning of the system was intermittent. Two 
issues were highlighted: First, the touch screen entered 
a hibernation mode if not being used. Being presented 
with a black—apparently broken—screen deterred use. 
Second, there were periods when the system was offline 
and unable to connect to the electronic medical records. 
Patients would follow the onscreen prompts to enter their 
personal details to be told that their medical record could 
not be identified: ‘The first time I found it really good…I 
managed to get all the information typed in properly and 
it took the reading very well, did what they said and that 
was great. But this time round it wouldn’t take my date of 
birth, it wouldn’t take who I was’ (patient ID17, practice 
B).
The design of the system was not fully integrated 
meaning that patients could use the BP monitor without 
using the touch screen. Some preferred this—it was faster 
and enabled them to take a single measurement instead 
of the three instructed by the touchscreen. As one GP 
described: ‘it’s quite a lot of steps to go through to get to 
the point where actually you measure it and as I recall it’s 
not terribly clear that you have to do all three readings’ 
(GP 1, practice A).
The solid-cuff monitor seemed well liked among the 
interviewees that had used it. Some elderly patients 
however were felt to struggle with the touch screen: 
‘You’d say, 'It’s really easy, just it’ll ask you the questions, 
you just go ahead’, and they’d be back at the desk saying, 
'Not working, not finding me,' and they’d just put some-
thing in wrong that was all, but it’s just older people and 
IT.’ (Reception team member, practice B). This may, in 
part, account for the relatively young age of kiosk users 
among the hypertensive population.
If unable or unwilling to use the electronic transfer, 
patients could hand their results into reception: ‘Some 
patients have mentioned that they’ve not been able to 
put their details in sometimes, but I just told them that 
you can still do it, press the button, it’ll give you the slip, 
and then you can hand it in to reception, so it shouldn’t 
necessarily be a hindrance, although it’s not ideal’ (GP 5, 
practice B). Often there were queues to speak to a recep-
tionist at practice B which was invariably described as 
‘very busy’ by staff and patients alike.
Having two parallel systems for results transfer 
presented challenges for patients, staff and the research 
team. It meant that duplicate instructions were needed: 
‘A lady stopped me and said, ‘Oh, please could you show 
me how to use this machine because it’s saying I’ve got 
to put my date of birth?’ So of course the screen’s not 
on but the piece of paper is saying, ‘You’ve got to put 
your date of birth’ (Practice nurse, practice A). Ad hoc 
procedures for manually entering and labelling these BP 
measurements in the electronic medical record emerged: 
‘Initially I think everybody was using all different codes to 
record it under’ (Reception team member, practice A). 
This made it difficult to internally audit kiosk use and also 
meant that this data was not included in the evaluation.
While the utilisation data presented here represent the 
lowest estimate of the kiosks’ use, they were all that was 
identifiable and auditable. Given the undemonstrated 
accuracy of BP measured in the waiting room compared 
that taken by a healthcare professional, its labelling and 
seamless inclusion in the medical record perhaps needs 
further thought: ‘I've seen several [waiting room] read-
ings… and the first reading could be like 188/120 or 
something and then the third reading is like normoten-
sive, so I personally think that if every reading just got 
chucked straight into the patient records is not ideal’ (GP 
4, practice B).
location and ownership
Each practice had to locate the self-screening kiosk within 
the constraints of available space. Practice A opted for a 
lobby, prior to entering the main waiting room, as this was 
felt to offer improved privacy. Several patients commented 
the kiosk was just something you walked passed on your 
way into the main surgery. At practice B, the kiosk was 
in the far corner of the waiting room: ‘ It's always quite 
difficult to get to because the chairs are sort of there and 
if there’s lots of people sitting there you have to ask them 
to move or not bother’ (patient ID30, Practice B)
In both practices, the equipment was felt to be in the 
domain of the reception team, for whom trying to resolve 
problems generated additional workload: ‘The only thing 
that I found a bit of a bother with it is that when it goes 
down sometime is that when I phone the helpline number, 
they’ve said their end they can see nothing wrong with it, 
and I’m not really good with computers… so you think 
you’re just doing something wrong yourself’ (Reception 
team member, practice B). The IT skills needed were 
beyond their usual responsibilities: ‘A couple of times 
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the practice manager did it [reset the system], and he 
worked it out, obviously he's very technical. I personally 
didn't have a clue’ (Reception team member, practice A). 
At both practices, the kiosk was placed behind a privacy 
screen preventing receptionists from being able to see 
if the touchscreen was working from their desk. Despite 
paying for a support contract, the system providers did not 
contact the practices to investigate periods of non-usage 
or the system being offline. At the same time, with the 
manual system for results transfer working on a-day-to-day 
basis, there was little motivation for practice staff to get 
the delicate electronic system working again.
Impact
Unsurprisingly, given the low usage observed, clinical staff 
did not notice an impact on their workload. Furthermore, 
GPs felt that if it did improve hypertension detection, this 
would generate additional—although important—work.
Encouraging patients to use the system and release any 
downstream benefits required investment by the practice: 
‘ I try and champion it to patients…and if they’ve come 
in for a blood pressure check, I say, 'Oh, did you know we 
have a machine in the waiting room where you can get it 
checked?’ We get a mixed response from that, some are 
quite enthusiastic and want to try it, and others, they’re 
not so keen’ (GP 4, practice B). At practice A—located 
in a smaller building, where clinicians collected patients 
for their appointments in person, it was more feasible to 
demonstrate to patients how to use the system. Practice B 
was initially proactive in promoting the system remotely 
via text message and letter: ‘I got a letter from the doctor 
to say, 'we haven’t recently had a blood pressure monitor 
from you for a while. Would you like to just come in and 
do a test? You don’t have to see the GP’ (patient ID17, 
practice B). However, following the departure of the prac-
tice manager—who acted as this service champion—this 
did not continue. At both practices, GPs reflected that 
they could have done more to promote the use of the 
kiosk but this was difficult day to day.
DIsCussIOn
Few studies have previously evaluated the impact of BP 
self-screening on hypertension diagnosis rates.11 In this 
study, we evaluated the feasibility of using a kiosk linked to 
the electronic medical records system in order to address 
this knowledge gap. We found that the provision of kiosks 
for BP measurement in practice waiting rooms resulted in 
few patients (1.2%) with self-screened BP measurements 
in their medical records. This was considerably less than 
previously reported screening rates in a systematic review 
of community-based hypertension screening.11 This led to 
self-screening being more expensive for GP practices than 
their current provision of care. While checking BP in the 
waiting room was broadly found to be an appropriate and 
acceptable activity, the electronic transfer system was not 
robust or effective at capturing the BP data. Given that 
the latter constituted the vast majority of the cost, such a 
kiosk cannot be currently recommended. Further exper-
imental work, such as a trial, is unlikely to be worthwhile 
without considerable changes to either increase patient 
usage or improve the technical functionality.
The mixed-methods nature of this study was a major 
strength, providing quantitative data on the performance 
of the kiosks and their cost-effectiveness, and qualitative 
interviews to identify the strengths and weaknesses of the 
system and how it fitted into the workflow of a GP surgery. 
We were able to replicate real-life implementation of an 
existing commercial system in two geographically sepa-
rated NHS GP practices with different populations, and 
using different electronic health records, ensuring that 
any results were not limited to a specific UK popula-
tion. However, this was a small scale feasibility study, and 
was limited to the UK GP setting. While we intended to 
recruit pharmacies to the study, we were unable to find a 
viable business model for pharmacy BP kiosks in the UK 
market. In addition, significant technical issues with the 
automated data transfer system limited the data available.
While manufacturers and retailers emphasise the time-
saving benefits, GP interviewees suggested that increased 
self-screening could lead to improved detection and 
additional hypertension management workload. Further-
more, the screening accuracy of such systems remains 
unevaluated and therefore it is not yet possible to provide 
thresholds of self-screened BP to rule out hypertension, 
thus avoiding rechecking by healthcare professionals, 
although these are likely to be similar to those for ambu-
latory monitoring.21 In our study, we observed increased 
levels of GP workload at one site, and decreased levels at 
the other, indicating that any benefits may be contingent.
Simple cost analysis showed that, at the rate of usage 
and the size of practice in this evaluation, this kiosk 
would not be cost-effective. A simpler, cheaper system 
using administrative staff to enter the data instead of 
the computer link may be more appropriate for prac-
tices who wish to offer self-screening. We observed this 
was a frequent work around for technical problems with 
the kiosk. Previous research reported that these simpler 
systems were felt by primary care staff to be helpful in 
attaining performance targets and generally acceptable to 
both patients and staff.22–24 However, while Hamilton et al 
successfully recruited community sites to host standalone 
BP monitors in a study of hypertension self-screening, 
many users did not supply their hand-written results slip 
to their GP.25 This highlights the difficulties of ensuring 
BP self-screening follow-up, whether ‘high tech’ or ‘low 
tech’ systems are used.
Our results suggest that a kiosk located at the surgery 
does not necessarily extend the screening reach of prac-
tices. Future work could investigate how to promote 
self-screening in order to increase usage particularly 
among groups less likely to have their BP checked. For 
example, men are known to have lower consultation rates 
than women.26 However, a very significant increase in 
usage from such activities would be required simply to 
avoid a loss of reach compared with current provisions 
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of care. We were unable to quantify the extent to which 
other methods of self-screening, such as use of the kiosk 
without automated transfer or home measurement of BP, 
were used during the study.
While novel technologies can be very appealing,27 
their adoption into daily practice can be challenging.28 
For example, the reception teams in our study found the 
requirements of the automated transfer associated with 
the kiosk to be beyond their typical responsibilities and, 
in some cases, expertise. Greenhalgh et al published a 
framework to help predict the success of healthcare tech-
nologies.29 The kiosk used in this study scores ‘compli-
cated’ under several domains: first, the technology is 
not 100% reliable with the manufacturer’s claims about 
data capture not being achieved. We are aware of other 
BP self-screening systems with automated data transfer 
technology experiencing similar problems that also only 
become apparent on data extraction (McManus, personal 
communication). Second, the value proposition is unclear 
with the very poor efficacy and cost-effectiveness in this 
feasibility work. Third, as noted above, existing staff must 
learn new skills or new staff hired which may counter 
balance any savings even in a well-used service. Finally, 
there is the restricted capacity of GP practices to change 
given their limited resources, variable leadership and 
managerial relations. Together these suggest that further 
work is needed prior to considering the widespread intro-
duction of BP self-screening systems linked to the prac-
tice electronic medical records in primary care. Providing 
healthcare commissioners and GP practices with informa-
tion such as this will help them make informed decisions 
when contemplating the charms of new technologies in 
an environment of resource constraint and opportunity 
costs.
COnClusIOns
These results indicate that a larger scale trial using 
the same methods and equipment is not, at this stage, 
feasible, nor can the self-screening equipment with auto-
mated data transfer tested in this study be recommended 
for use in primary care. The findings also highlight uncer-
tainty about the robustness of such a system for use in 
daily clinical practice.
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